Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lader, Malcolm
2000.
Rating Scales in Schizophrenia.
CNS Drugs,
Vol. 14,
Issue. 1,
p.
23.
Maidment, Ian
2000.
Use of serotonin antagonists in the treatment of neuroleptic-induced akathisia.
Psychiatric Bulletin,
Vol. 24,
Issue. 9,
p.
348.
Lund, Brian C
and
Perry, Paul J
2000.
Olanzapine: an atypical antipsychotic for schizophrenia.
Expert Opinion on Pharmacotherapy,
Vol. 1,
Issue. 2,
p.
305.
Tollefson, Gary D.
and
Taylor, Cindy C.
2000.
Olanzapine: Preclinical and Clinical Profiles of a Novel Antipsychotic Agent.
CNS Drug Reviews,
Vol. 6,
Issue. 4,
p.
303.
Tohen, Mauricio
Jacobs, Thomas G
and
Feldman, Peter D
2000.
Onset of action of antipsychotics in the treatment of mania.
Bipolar Disorders,
Vol. 2,
Issue. 3p2,
p.
261.
Duggan, L
Fenton, M
Dardennes, RM
El-Dosoky, A
and
Indran, S
2000.
Cochrane Database of Systematic Reviews.
Hormaechea, Juan A
García, Luis E
Prieto, Luis
and
Gómez, Juan C
2001.
Comparison of older and newer neuroleptics for the treatment of schizophrenia.
Expert Review of Neurotherapeutics,
Vol. 1,
Issue. 2,
p.
161.
Kasper, S.
Jones, M.
and
Duchesne, I.
2001.
Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): health economic results of an international naturalistic study.
International Clinical Psychopharmacology,
Vol. 16,
Issue. 4,
p.
189.
Otte, C.
Lambert, M.
and
Naber, D.
2001.
Leponex.
p.
50.
Tohen, Mauricio
Zhang, Fan
Keck, Paul E.
Feldman, Peter D.
Risser, Richard C.
Tran, Pierre V.
and
Breier, Alan
2001.
Olanzapine versus haloperidol in schizoaffective disorder, bipolar type.
Journal of Affective Disorders,
Vol. 67,
Issue. 1-3,
p.
133.
Wetterling, Tilman
2001.
Bodyweight Gain with Atypical Antipsychotics.
Drug Safety,
Vol. 24,
Issue. 1,
p.
59.
Keck, Paul E.
Reeves, Karen R.
and
Harrigan, Edmund P.
2001.
Ziprasidone in the Short-Term Treatment of Patients with Schizoaffective Disorder: Results from Two Double-Blind, Placebo-Controlled, Multicenter Studies.
Journal of Clinical Psychopharmacology,
Vol. 21,
Issue. 1,
p.
27.
Gonzalez-Pinto, A.
Lalaguna, B.
Mosquera, F.
Pérez de Heredia, J.L.
Gutierrez, M.
Ezcurra, J.
Gilaberte, I.
and
Tohen, M.
2001.
Use of olanzapine in dysphoric mania.
Journal of Affective Disorders,
Vol. 66,
Issue. 2-3,
p.
247.
Carvajal, Alfonso
and
Martín Arias, Luis H.
2001.
Vol. 24,
Issue. ,
p.
53.
Lambert, Martin
Holzbach, R??diger
Moritz, Steffen
Postel, Nils
Krausz, Michael
and
Naber, Dieter
2003.
Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders.
International Clinical Psychopharmacology,
Vol. 18,
Issue. 5,
p.
251.
Cipriani, A
Rendell, J
Geddes, J
and
Cipriani, Andrea
2003.
The Cochrane Database of Systematic Reviews.
Lucey, JV
and
Libretto, SE
2003.
Risperidone compared with olanzapine in a naturalistic clinical study in Ireland: a cost analysis.
Irish Journal of Medical Science,
Vol. 172,
Issue. 4,
p.
195.
Gianfrancesco, Frank
White, Richard
Wang, Ruey-hua
and
Nasrallah, Henry A.
2003.
Antipsychotic-Induced Type 2 Diabetes: Evidence From a Large Health Plan Database.
Journal of Clinical Psychopharmacology,
Vol. 23,
Issue. 4,
p.
328.
Advokat, Claire
Dixon, Dennis
Schneider, Jeffrey
and
Comaty, Joseph E
2004.
Comparison of risperidone and olanzapine as used under “real-world” conditions in a state psychiatric hospital.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 28,
Issue. 3,
p.
487.
Mensink, G. J. R.
and
Slooff, C. J.
2004.
Novel antipsychotics in bipolar and schizoaffective mania.
Acta Psychiatrica Scandinavica,
Vol. 109,
Issue. 6,
p.
405.
eLetters
No eLetters have been published for this article.